Content Hub

Preclinical Development of 212Pb-DOTAMTATE in a Neuroendocrine Tumor Model

Amal Saidi, Scientist, OranoMed

Want to see the exciting line-up for 2020?

Targeted alpha therapy with212Pb-NNV003 for thetreatmentof CD37 positive B-cellChronicLymphocyticLeukemia(CLL) and Non-HodgkinLymphoma(NHL)

Jostein Dahle